Abstract The Wnt signaling pathway is involved in the regulation of tissue patterning and organ development during embryogenesis and continues to contribute to the maintenance of tissue homeostasis in adulthood. Recently, Wnt signaling has also been implicated in the establishment and progression of replicative cellular senescence. Given the known roles of tissue homeostasis and cellular senescence in aging, we sought to determine whether Wnt signaling changes with age. We examined the expression of 84 Wnt pathway-related genes in the liver, lung, skeletal muscle, and brain tissue from young and old mice. Expression changes were compared with those seen in cellular senescence, and transcription factors that might mediate these changes were predicted bioinformatically. In aggregate, our data are indicative of a general decrease in Wnt signaling with age, especially in the lung and brain. Furthermore, the set of genes that are differentially expressed with age is distinct from the genes differentially expressed in cellular senescence. The transcription factors predicted to regulate these changes, Nf-κB, Myb, Nkx2-1, Nr5a2, and Ep300, are known to regulate inflammation, differentiation, lipid metabolism, and chromatin remodeling, all of which have previously been implicated in aging. Although our study does not address whether altered Wnt signaling is a cause or an effect of aging, the presence of a relationship between the two provides a starting point for further investigation.
Introduction
Aging is a gradual deleterious process that underlies the pathogenesis of the majority of diseases responsible for human morbidity and mortality. Though the etiology of aging is not fully understood, there is abundant evidence that it is not simply caused by the accumulation of damage but rather is governed by genetic mechanisms (Kenyon 2010) . Elucidation of these mechanisms would greatly accelerate our ability to formulate effective therapies to treat or prevent some of the most prevalent diseases of the modern world.
Aging of the cell can be broken down into two categories: chronological and replicative. Chronological aging is largely due to the accumulation of damaged or destructive molecules that impair the function of the cell, and it has the strongest effects in terminally differentiated cells which are unable to dilute these molecules through cell division. Replicative aging is the damage caused by proliferation such as shortening of telomeres. Replicative aging can ultimately result in replicative cellular senescence, causing cells to cease proliferation and adopt the senescence-associated secretory phenotype, in which they secrete inflammatory molecules that damage their local environment. The proportion of cells that have entered replicative senescence increases with age, but the mechanisms underlying this progression are not fully understood (Krishnamurthy et al. 2004; Tchkonia et al. 2010; Wang et al. 2009 ).
Recent work has implicated the Wnt signaling pathway in replicative senescence and, thereby, aging (Ye et al. 2007) . Though the Wnt pathway is mostly known for its role in morphogenic signaling during embryonic development, there are some reports of its involvement in homeostasis of adult tissues and stem cell maintenance (Alonso and Fuchs 2003; Boj et al. 2012; Hu et al. 2007; Reya et al. 2003) . Wnt signaling naturally declines in senescent cells, and its repression induces cellular senescence (Ye et al. 2007 ). There is also evidence that dysfunctional Wnt signaling is pathogenic in many aging-related diseases. The decline of Wnt signaling with age contributes to the pathogenesis of osteoporosis (Almeida et al. 2007; Bennett et al. 2005 ), Alzheimer's disease, and Parkinson's disease (Berwick and Harvey 2012) ; increased Wnt signaling with age is thought to cause fibrosis in skeletal muscle, resulting in sarcopenia (Arthur and Cooley 2012) ; and a variant of TCF7L2, a transcriptional effector of the Wnt pathway, increases the risk of type II diabetes (Grant et al. 2006) . Attaining a greater understanding of the relationship between aging and Wnt signaling in vivo would be valuable in the study of age-associated diseases and changes in physiology.
In the canonical Wnt signaling pathway, a soluble Wnt ligand binds to the Frizzled receptor (Fzd) and the LRP5/6 co-receptor on the plasma membrane, which activate the cytoplasmic protein Dishevelled (Dvl). Dvl inhibits the β-catenin (Ctnnb1) destruction complex (APC, GSK3β, and Axin), hence preventing the phosphorylation and consequent destruction of Ctnnb1. When it is stabilized as a result of active Wnt signaling, Ctnnb1 can translocate to the nucleus, form a complex with Lef and Tcf transcription factors, and thereby activate transcription of target genes such as c-Myc and Cyclin D1. To investigate the effects of age on Wnt signaling, we used quantitative PCR arrays to measure the expression of 84 relevant genes, including those listed above as well as other inhibitors, modulators, and effectors of Wnt signaling in young and old mice. Determining which genes are differentially expressed with age in various tissues in vivo has revealed novel tissue-specific mechanisms by which organ function and homeostasis decline with time, as well as a greater understanding of the roles of Wnt signaling in adult animals.
Experimental procedures
Gene expression analysis Tissues were harvested from 5-and 36-month-old male C57BL/6J (Jackson Labs) mice purchased from the NIA and sacrificed in our facility and 24-month-old C57BL/ 6N (Charles River) mice that were bred and aged in our own facility. These two sub-strains of C57BL/6 differ by only 34 single nucleotide polymorphisms (SNPs) and 2 indels in coding regions and 146 SNPs and 54 indels in noncoding regions, none of which are within or near to any of the genes observed in this study (Simon et al. 2013) ; thus, variability due to strain is not expected to significantly affect our results. The following tissues were examined: liver, skeletal muscle, lung, and brain, although only liver and muscle were available from 24-month-old mice. Samples were homogenized in liquid nitrogen and then resuspended and further homogenized in TRIzol reagent according to the manufacturer's suggested protocol (Invitrogen). RNA was isolated using phenol chloroform extraction and purified using the RNeasy kit from QIAGEN. Quality of individual RNA preparations was verified using the Bioanalyzer (Agilent), and only samples with RIN>9 were used. Equal amounts of total RNA from ten 5-or 36-monthold mice, or five 24-month-old mice, were pooled, and then reverse transcription and quantitative PCR were performed in triplicate on the pooled samples. Gene expression was measured using the mouse Wnt signaling pathway RT 2 Profiler PCR Array (SABiosciences/ QIAGEN, PAMM-043E-4) using the manufacturer's protocols. This array contains primers corresponding to 84 genes related to the Wnt pathway, five housekeeping genes for normalization, and positive and negative controls for the PCR reaction (raw data are provided in Table S1 ). Genes were considered to be differentially expressed if their expression differed by at least twofold in either direction between either 5-and 24-or 5-and 36-month-old mice, and that difference was statistically significant across technical replicates.
Transcription factor prediction
The Transfac software package was used to predict which transcription factors are most likely to cause the observed changes in gene expression. Promoter sequences were defined as −1,000 to +200 bp relative to the transcription start site, and loci within each promoter that were at least a 90 % match to a transcription factor binding site were identified and summed to create a score for each transcription factor for each gene. To predict whether each transcription factor regulates agerelated changes in Wnt signaling, its scores for genes that were differentially expressed between 5-and 36-month-old mice were compared to its scores for genes that were not differentially expressed with age, and a two-tailed t test was used to determine whether the promoters of differentially expressed genes were more enriched for binding sites than promoters of nondifferentially expressed genes.
Results

Assessment of variability
To verify that the detection of differentially expressed genes was not adversely affected by pooling samples from different animals, mRNA quantity of Ccnd2 in the liver and Lef1 in the lung was measured by qPCR on samples from individual animals (Fig. 1) . Biological variability was low and the effect of age was similar to that observed in the pooled samples: average expression and standard deviation in arbitrary units for Ccnd2 were 0.905±0.081 in young and 2.138±0.457 in old and for Lef1 were 1.408±0.074 in young and 0.515±0.010 in old. This indicates that pooling of RNA samples from different animals is unlikely to reduce the accuracy of our findings.
Liver
Several genes related to Wnt signaling were differentially expressed with age in the liver, although the implications of these changes for Wnt pathway activity are somewhat contradictory and hence remain uncertain (Fig. 2a) . Wnt11 expression decreased with age, whereas Wnt6 expression increased, and neither was among the Wnt ligands with high expression in the liver (Fig. 3a) . Extracellular inhibitors of Wnt ligands had higher expression in the liver from older mice (Frzb, Sfrp1), which suggests less Wnt signaling. However, some positive mediators of Wnt signaling had greater expression in old liver (Dvl), while others had reduced expression (Fzd2, Fzd3). The same dichotomy was exhibited by the transcription factors that drive Wnt-dependent expression (Lef1, Tcf3). Among genes whose expression is regulated by Wnt signaling, Ccnd1 and Ccnd2 were upregulated in old mice. However, their transcriptional regulation is known to be multifactorial and could thus be driven by other means. In summary, we cannot draw strong conclusions about the effects of age on Wnt signaling in the liver from these data.
Brain
Wnt signaling appeared to decrease with age in the brain (Fig. 2b) . All genes related to the Wnt pathway whose expression changed with age in the brain showed decreased expression in old mice. Among these genes was a positive mediator of Wnt signaling (Dixdc1), a transcriptional output (Ccnd2), two Wnt-dependent ligand that had the greatest expression in the brain (Fig. 3b) , so its decreased expression is particularly likely to indicate a functional effect on Wnt signaling in this tissue. Fig. 1 Relative expression of Ccnd1 and Lef1 in the liver and lung, respectively, measured by qPCR of samples from 5-or 36-month-old male mice. Seven to ten individual mice were used for each group, and a two-tailed t test was used to compute p values. Expression is reported in arbitrary units, determined by normalization to Gapdh in each sample AGE (2014) Their downregulation collectively implies less Wnt signaling. Overall, the most likely explanation of these changes is that Wnt signaling is decreased, and therefore, less inhibition is needed to keep it in check. This is supported by the magnitude of the observed expression changes, namely, that the decreases in the expression of genes that positively affect Wnt signaling are more substantial than the decreases in the expression of inhibitors of the pathway. Although c-Myc expression is inconsistent with this interpretation, c-Myc is regulated by a diverse set of genes and physiologic parameters, and its upregulation with age may not be related to Wnt signaling.
Lung
Wnt signaling also decreased with age in the lung. Tle1 and Lef1, which positively mediate Wnt signaling, showed decreased expression; Frzb, an extracellular Wnt ligand inhibitor, had greater expression; and Nkd1, whose expression is driven by Wnt signaling and also provides negative feedback, had decreased expression with age (Fig. 2d) . All of these changes are indicative of reduced Wnt signaling. The Wnt ligand Wnt10a was upregulated in older animals but was one of the least expressed Wnt ligands in the lung. Although it is quite possible that the differential expression of Wnt10a has physiological significance, it is unlikely to represent overall pathway activity because it is opposed by several other components of the pathway that are expressed at much higher levels (Fig. 3d) .
Transcription factor analysis
We used the bioinformatics package Transfac to predict which transcription factors (TFs) might regulate the genes that were differentially expressed with age in a manner consistent with the direction of change. TFbinding affinity was computed between each of 2,200 transcription factors and the promoter of each differentially expressed gene using known TF-binding sites in the Transfac database. For each transcription factor, the average score across differentially expressed genes was compared to that of genes in our dataset that were not differentially expressed. This analysis was performed on skeletal muscle since it had the greatest number of differentially expressed genes of all the tissues studied and therefore was most likely to yield reliable results. The transcription factors that are statistically more likely to regulate differentially expressed genes are NF-κB, Myb, Nkx2-1, Nr5a2, and Ep300 (Table 1) . Neither a literature search nor the bioinformatics package Ingenuity (Ingenuity Systems) revealed existing experimentally validated evidence linking any of these transcription factors with the regulation of more than one of the differentially expressed genes. Thus, the transcription factors identified here are potentially novel regulators of the age-dependent Wnt signaling changes in skeletal muscle.
Comparison with cellular senescence
Wnt signaling has been implicated in regulating cellular senescence (Ye et al. 2007) , and the frequency of senescent cells increases in several tissues with age (Krishnamurthy et al. 2004; Tchkonia et al. 2010; Wang et al. 2009 ). One possible hypothesis thus would be that the differential expression of Wnt pathway genes observed in this study reflects the changing proportion of senescent cells with age. To address this, the set of genes differentially expressed with age in our dataset was compared with a list of genes found to be differentially expressed in either oncogene-induced senescence or replicative senescence (Nelson et al. 2014) . Additionally, the known transcriptional outputs of Wnt signaling that were differentially expressed in senescent cells (Nelson et al. 2014) were referenced in whole genome microarray data comparing gene expression in the liver, skeletal muscle, and adipose tissue of young and old mice (our unpublished data). In both comparisons of organismal aging and cellular senescence, no significant correlations were found for genes that comprise the Wnt signaling pathway. Therefore, the expression changes we have described above are unlikely to be caused by age-related increases in cellular senescence.
Discussion
Overall, our analysis indicates that Wnt signaling tends to decrease with age in mouse tissues. Although the effect of age on Wnt signaling in the liver was ambiguous, it is likely that it decreases with age in skeletal muscle, and there was clear repression with age in both the brain and lung. This repression of gene expression was distributed across the pathway, with decreases in Wnt ligands as well as both cytoplasmic and nuclear mediators of Wnt signaling. Although some of the differentially expressed Wnt ligands have low expression relative to other Wnt ligands expressed in the same tissue, evidence in the literature suggests that such "minor" ligands can affect the physiology of that tissue in a meaningful way. For example, Wnt7a is one of the Wnt ligands with the lowest expression in skeletal muscle, but its effects on muscle regeneration via stem cell activation (Le Grand et al. 2009 ) and activation of the mTOR pathway to induce muscle growth (von Maltzahn et al. 2012 ) have been well established. Consequently, it would not be surprising if the drastic decrease in Wnt7a expression with age we observed in skeletal muscle underlies the age-related impairment of this tissue. Although Wnt signaling has been shown to decline in senescent cells and the number of senescent cells increases in many tissues with age, a comparison of the expression changes caused by either organismal aging or cellular senescence suggests that the effects of each on Wnt signaling are not related. This is consistent with the prevailing evidence that the frequency of senescent cells in tissues, even at advanced age, is likely to be quite low (Wang et al. 2009 ). In particular, skeletal muscle contains very few (if any) senescent cells, and their number does not seem to increase with age (Wang et al. 2009 ). Since the great majority of cells in skeletal muscle are mature myocytes (muscle fibers), the changes in the Wnt pathway we observed with age are likely attributable to this cell type.
To search for the cause of decreased Wnt signaling in old animals, we employed a computational approach to identify common regulators of differentially expressed genes. The transcription factors that were identified are known to regulate diverse biological functions, including inflammation, hematopoiesis, organ development, cholesterol metabolism, and chromatin remodeling. Both inflammation and chromatin remodeling are known to be inextricably tied to aging, so it would not be surprising if one or both of these were the cause of reduced Wnt signaling with age, potentially mediated by the transcriptional regulators NF-κB and/or Ep300. Additionally, our data suggest that the effects of processes like inflammation that are associated with aging a Scores indicate similarity between the binding motif for that transcription factor and sequences in the promoter region of a gene, and the average scores from differentially expressed or non-differentially expressed genes are listed. Statistics were computed using a two-tailed t test may be deleterious at least partially due to their interaction with Wnt signaling. It has been well documented that Wnt signaling positively influences adult stem and progenitor cell maintenance (Hoffman et al. 2004; Kuhnert et al. 2004) . This pathway has recently also emerged as potentially a key regulator of cellular senescence (Ye et al. 2007) . Consistent with these anti-aging properties, several reports have documented that inherited genetic polymorphisms that result in reduced Wnt signaling are associated with premature aging phenotypes such as heart disease, metabolic syndrome, Alzheimer's disease, osteoporosis, and diabetes (De Ferrari et al. 2007; Gong et al. 2001; Mani et al. 2007; Soriano et al. 2001; Welters and Kulkarni 2008) . This genetic evidence is consistent with the idea that maintenance of Wnt signaling is required for stem cell homeostasis and hence acts to delay aging processes. However, other lines of evidence suggest that over activation of the Wnt pathway can have pro-aging effects by promoting excessive tissue fibrosis (Chilosi et al. 2003) and thus accelerating the onset of tissue dysfunction and age-associated phenotypes (Brack et al. 2007; Liu et al. 2007 ). In sum, several different lines of evidence support the hypothesis that Wnt signaling impacts the aging processes. Whether Wnt signaling accelerates or delays aging and to what extent these effects are tissue specific remains to be worked out in detail. Our data presented here, based on expression analysis of Wnt pathway component genes in four major tissues of the mouse (liver, brain, skeletal muscle, and lung), are indicative of a general trend toward reduced activity of this pathway with age.
